Cargando…
Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease
OBJECTIVE: This study aims to analyse the possible recovery or worsening in retinal microvasculature after 8 months in a previously studied COVID-19 cohort. METHODS AND ANALYSIS: A cross-sectional case–control study and a prospective longitudinal cohort study. Participants were the subjects of our p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753095/ https://www.ncbi.nlm.nih.gov/pubmed/35039796 http://dx.doi.org/10.1136/bmjophth-2021-000867 |
_version_ | 1784632019676823552 |
---|---|
author | Banderas García, Sandra Aragón, David Azarfane, Brahim Trejo, Fernando Garrell-Salat, Xavier Sánchez-Montalvá, Adrián Otero-Romero, Susana Garcia-Arumi, Jose Zapata, Miguel Angel |
author_facet | Banderas García, Sandra Aragón, David Azarfane, Brahim Trejo, Fernando Garrell-Salat, Xavier Sánchez-Montalvá, Adrián Otero-Romero, Susana Garcia-Arumi, Jose Zapata, Miguel Angel |
author_sort | Banderas García, Sandra |
collection | PubMed |
description | OBJECTIVE: This study aims to analyse the possible recovery or worsening in retinal microvasculature after 8 months in a previously studied COVID-19 cohort. METHODS AND ANALYSIS: A cross-sectional case–control study and a prospective longitudinal cohort study. Participants were the subjects of our previous study who re-enrolled for a new examination including a fundus photograph (retinography), an optical coherence tomography (OCT) scan and an OCT angiography. COVID-19 diagnosed patients were divided into three groups: group 1: mild disease, asymptomatic/paucisymptomatic subjects who received outpatient care; group 2: moderate disease and group 3: severe disease, both of which required hospital admission because of pneumonia. Statistical analyses were performed using SPSS software (V.23.0). Cross-sectional intergroup differences were analysed by means of analysis of variance for normally distributed variables and the Kruskal-Wallis test for non-normally distributed ones. In reference to the prospective part of the study (intragroup differences, baseline with 8-month comparison), a paired t-test was used for normally distributed data and Wilcoxon signed ranks sum for non-normally distributed data. RESULTS: The fovea-centered superficial and deep vascular densities were significantly diminished in severe cases compared with mild cases (p=0.004; p=0.003, respectively, for superficial and deep) and to controls (p=0.014; p=0.010), also in moderate cases to mild group (p=0.004; p=0.003) and to controls (p=0.012; p=0.024). In the longitudinal study, no significant statistical differences were found between baseline and 8-month follow-up vessel density values. CONCLUSION: We demonstrated persistent reduction in the central vascular area over time in patients with moderate and severe COVID-19. |
format | Online Article Text |
id | pubmed-8753095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87530952022-01-13 Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease Banderas García, Sandra Aragón, David Azarfane, Brahim Trejo, Fernando Garrell-Salat, Xavier Sánchez-Montalvá, Adrián Otero-Romero, Susana Garcia-Arumi, Jose Zapata, Miguel Angel BMJ Open Ophthalmol Retina OBJECTIVE: This study aims to analyse the possible recovery or worsening in retinal microvasculature after 8 months in a previously studied COVID-19 cohort. METHODS AND ANALYSIS: A cross-sectional case–control study and a prospective longitudinal cohort study. Participants were the subjects of our previous study who re-enrolled for a new examination including a fundus photograph (retinography), an optical coherence tomography (OCT) scan and an OCT angiography. COVID-19 diagnosed patients were divided into three groups: group 1: mild disease, asymptomatic/paucisymptomatic subjects who received outpatient care; group 2: moderate disease and group 3: severe disease, both of which required hospital admission because of pneumonia. Statistical analyses were performed using SPSS software (V.23.0). Cross-sectional intergroup differences were analysed by means of analysis of variance for normally distributed variables and the Kruskal-Wallis test for non-normally distributed ones. In reference to the prospective part of the study (intragroup differences, baseline with 8-month comparison), a paired t-test was used for normally distributed data and Wilcoxon signed ranks sum for non-normally distributed data. RESULTS: The fovea-centered superficial and deep vascular densities were significantly diminished in severe cases compared with mild cases (p=0.004; p=0.003, respectively, for superficial and deep) and to controls (p=0.014; p=0.010), also in moderate cases to mild group (p=0.004; p=0.003) and to controls (p=0.012; p=0.024). In the longitudinal study, no significant statistical differences were found between baseline and 8-month follow-up vessel density values. CONCLUSION: We demonstrated persistent reduction in the central vascular area over time in patients with moderate and severe COVID-19. BMJ Publishing Group 2022-01-11 /pmc/articles/PMC8753095/ /pubmed/35039796 http://dx.doi.org/10.1136/bmjophth-2021-000867 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Retina Banderas García, Sandra Aragón, David Azarfane, Brahim Trejo, Fernando Garrell-Salat, Xavier Sánchez-Montalvá, Adrián Otero-Romero, Susana Garcia-Arumi, Jose Zapata, Miguel Angel Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title | Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title_full | Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title_fullStr | Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title_full_unstemmed | Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title_short | Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease |
title_sort | persistent reduction of retinal microvascular vessel density in patients with moderate and severe covid-19 disease |
topic | Retina |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753095/ https://www.ncbi.nlm.nih.gov/pubmed/35039796 http://dx.doi.org/10.1136/bmjophth-2021-000867 |
work_keys_str_mv | AT banderasgarciasandra persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT aragondavid persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT azarfanebrahim persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT trejofernando persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT garrellsalatxavier persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT sanchezmontalvaadrian persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT oteroromerosusana persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT garciaarumijose persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease AT zapatamiguelangel persistentreductionofretinalmicrovascularvesseldensityinpatientswithmoderateandseverecovid19disease |